These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 22777958)
1. Cyclosquaramides as kinase inhibitors with anticancer activity. Villalonga P; Fernández de Mattos S; Ramis G; Obrador-Hevia A; Sampedro A; Rotger C; Costa A ChemMedChem; 2012 Aug; 7(8):1472-80. PubMed ID: 22777958 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents. Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of novel indirubin-5-carboxamides. Cheng X; Rasqué P; Vatter S; Merz KH; Eisenbrand G Bioorg Med Chem; 2010 Jun; 18(12):4509-15. PubMed ID: 20488718 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116 [TBL] [Abstract][Full Text] [Related]
5. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies. Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559 [TBL] [Abstract][Full Text] [Related]
6. Development of new fluorescent xanthines as kinase inhibitors. Kim D; Jun H; Lee H; Hong SS; Hong S Org Lett; 2010 Mar; 12(6):1212-5. PubMed ID: 20184370 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors. Zhan W; Li Y; Huang W; Zhao Y; Yao Z; Yu S; Yuan S; Jiang F; Yao S; Li S Bioorg Med Chem; 2012 Jul; 20(14):4323-9. PubMed ID: 22721924 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors. Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives. El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors. Zhang D; Ai J; Liang Z; Li C; Peng X; Ji Y; Jiang H; Geng M; Luo C; Liu H Bioorg Med Chem; 2012 Sep; 20(17):5169-80. PubMed ID: 22863529 [TBL] [Abstract][Full Text] [Related]
11. Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors. Tao ZF; Wang L; Stewart KD; Chen Z; Gu W; Bui MH; Merta P; Zhang H; Kovar P; Johnson E; Park C; Judge R; Rosenberg S; Sowin T; Lin NH J Med Chem; 2007 Apr; 50(7):1514-27. PubMed ID: 17352464 [TBL] [Abstract][Full Text] [Related]
12. Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives. Shallal HM; Russu WA Eur J Med Chem; 2011 Jun; 46(6):2043-57. PubMed ID: 21429632 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors. N'gompaza-Diarra J; Bettayeb K; Gresh N; Meijer L; Oumata N Eur J Med Chem; 2012 Oct; 56():210-6. PubMed ID: 22982525 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and protein kinase binding activities of Some N6, 5'-bis-ureido 5'-amino-5'-deoxyadenosine derivatives. Peterson MA; Oliveira M; Christiansen MA Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):394-407. PubMed ID: 20183591 [TBL] [Abstract][Full Text] [Related]
16. New thiazole carboxamides as potent inhibitors of Akt kinases. Chang S; Zhang Z; Zhuang X; Luo J; Cao X; Li H; Tu Z; Lu X; Ren X; Ding K Bioorg Med Chem Lett; 2012 Jan; 22(2):1208-12. PubMed ID: 22172705 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835 [TBL] [Abstract][Full Text] [Related]
18. New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies. Koh EJ; El-Gamal MI; Oh CH; Lee SH; Sim T; Kim G; Choi HS; Hong JH; Lee SG; Yoo KH Eur J Med Chem; 2013; 70():10-21. PubMed ID: 24128410 [TBL] [Abstract][Full Text] [Related]
19. Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors. Elsayed MS; El-Araby ME; Serya RA; El-Khatib AH; Linscheid MW; Abouzid KA Eur J Med Chem; 2013 Mar; 61():122-31. PubMed ID: 23063746 [TBL] [Abstract][Full Text] [Related]
20. Isosteric replacement of the Z-enone with haloethyl ketone and E-enone in a resorcylic acid lactone series and biological evaluation. Napolitano C; Natoni A; Santocanale C; Evensen L; Lorens JB; Murphy PV Bioorg Med Chem Lett; 2011 Feb; 21(4):1167-70. PubMed ID: 21273066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]